Brinton Pharmaceuticals Limited - Company Profile

It is a pharma public limited company based in Pune, Maharashtra, India, established in 2013.
2013 Pune, Maharashtra, India Active
Last Updated:
Access Report
About Brinton Pharmaceuticals Limited

Brinton Pharmaceuticals Limited, a active public limited company, was established on 27 September 2013 in Pune, Maharashtra, India. Engaging in drug formulation & development within the trade sector, it holds CIN: U24232PN2013PLC148971. Registered under ROC Roc Pune. it is unlisted. It has an authorized capital of ₹2.00 Cr and a paid-up capital of ₹1.09 Cr.

It upholds a compliant status. Employing 508 professional, Its leadership includes Rahul Kundanmal Darda (Managing Director), Ronak Hemprakash Shah (Director), Chaitali Rahul Darda (Director). Past directors included Bonnie Ann Marie Weekes, Rahul Kundanmal Darda, Kerry Donald Bell. It holds ₹75.25 Cr open charges and ₹81.50 Cr settled loans. Its latest AGM occurred on 30 September 2024, with the balance sheet filed on 31 March 2024. It is based at S. No 55/2 Kharadi, Taluka Haveli, Pune, Maharashtra, 411014.

Company Details
  • Email
    **********
  • Telephone

    +91-XXXXXXXXXX

  • Website
    **********
  • Social Media
    **********
  • Apps
    **********

Company Details

  • CIN/LLPIN

    U24232PN2013PLC148971

  • Registration Number

    148971

  • Incorporation Date

    27 September 2013

  • Authorized Capital

    ₹2.00 Cr

  • Paid-Up Capital

    ₹1.09 Cr

  • ROC Code

    Roc Pune

  • Listing Status

    Unlisted

  • Company Status

    Active

Key Metrics
  • Authorised Capital ₹ 2.00 Cr
  • Paid Up Capital ₹ 1.09 Cr
  • Company Age 12 Year, 4 Months
  • Last Filing with ROC 31 Mar 2024
  • Open Charges ₹ 75.25 Cr
  • Satisfied Charges ₹ 81.50 Cr
  • Revenue Growth **** 40.36%
  • Profit Growth **** -5.95%
  • Ebitda **** 336.52%
  • Net Worth 22.26%
  • Total Assets **** 42.09%
Company report

Brinton Pharmaceuticals Limited

Company Report FY 2025-2026

Comprehensive Company Insights

Explore comprehensive insights into Brinton Pharmaceuticals Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report Banner Element
Who are the key members and board of directors at Brinton Pharmaceuticals Limited?
Current Directors
Name Designation Appointment Date Status
Rahul Kundanmal Darda Managing Director 27 Sep 2013 Current
Ronak Hemprakash Shah Director 28 Mar 2024 Current
Chaitali Rahul Darda Director 27 Sep 2013 Current
Shivani Bhasin Nominee Director 13 Jun 2019 Current
Visalakshi Chandramouli Nominee Director 30 Mar 2017 Current
Sudeep Chhallani Director 28 Mar 2024 Current
Past Directors
Name Designation Cessation Status
Pramod Abcsdd Additional Director 03 Sep 2016 Past
Pramod Abcsdd Director 01 Apr 2021 Past
Pramod Abcsdd Additional Director 31 Aug 2015 Past
Pramod Abcsdd Company Secretary - Past
Pramod Abcsdd Additional Director 13 Jun 2019 Past
Pramod Abcsdd Director 30 Jun 2019 Past

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Brinton Pharmaceuticals.

Brinton Pharmaceuticals Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 40.36% increase. The company also saw a slight decrease in profitability, with a 5.95% decrease in profit. The company's net worth Soared by an impressive increase of 22.26%.

Brinton Pharmaceuticals revenue growth over time
Brinton Pharmaceuticals profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors
Emtek
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
Jan, 2021 Amount Post-IPO - Grab Valuation

investors
Hana Financial Group , GGV Capital
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023) YOY Growth
(FY 2022) (FY 2021) (FY 2020) (FY 2019)
Total Revenue
********
 40.36%
*******
*******
*******
*******
Revenue from Operations
*******
 40.23%
*******
*******
*******
*******
Total Assets
*******
 42.09%
*******
*******
*******
*******
Profit or Loss
*******
 -5.95%
*******
*******
*******
*******
Net Worth
*******
 22.26%
*******
*******
*******
*******
EBITDA
*******
 336.52%
*******
*******
*******
*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Brinton Pharmaceuticals?

In 2023, Brinton Pharmaceuticals had a promoter holding of 87.87% and a public holding of 12.13%. The company had 1 Subsidiary. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.

Shareholding Pattern (FY 2024)
shareholding
  • Promoters: 92.83%
  • Public: 4.10%
  • Others: 3.07%
Shareholding Pattern over the Year
FY (2024) FY (2023) FY (2022) FY (2021) FY (2020)
Promoters 92.83 94.62 94.55 94.55 94.55
Public 4.10 3.89 3.95 3.96 3.98
Others 3.07 1.49 1.50 1.49 1.47

Reveal ownership structures and financial performance - Get instant access now!

Charges (Loans)
Open Charges

₹752,500,000.00

Satisfied Charges

₹815,000,000.00

Charges Breakdown by Lending Institutions
  • Others : 75.25 Cr
Latest Charge Details
Date Lender Amount Status
27 Mar 2025 Others ₹75.00 Cr Open
04 Aug 2020 Others ₹2.50 M Open
04 Sep 2024 Others ₹4.00 Cr Satisfied
27 Jun 2023 Others ₹7.50 Cr Satisfied
09 Jun 2023 Others ₹3.00 Cr Satisfied

Explore comprehensive loan charge details -

How Many Employees Work at Brinton Pharmaceuticals?

Brinton Pharmaceuticals has a workforce of 508 employees as of Apr 02, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.

Employee Date Number of Employees
2020 78,000
2021 80,500
2022 83,200
2023 86,000
2024 89,500
2025 92,000
Deals i
Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Brinton Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Brinton Pharmaceuticals's trajectory.

Rating
Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts
Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Brinton Pharmaceuticals
Recent Activity within the Organization
  • Charges

    Progress on A charge registered on 30 Aug 2021 via Charge ID 100514652 with Others was fully satisfied on 17 Apr 2025. was documented.

  • Charges

    The activity A charge registered on 09 Jun 2023 via Charge ID 100730089 with Others was fully satisfied on 16 Apr 2025. was completed.

  • Charges

    A charge registered on 31 Jan 2023 via Charge ID 100673056 with Others was fully satisfied on 15 Apr 2025. was recorded as a recent event.

  • Charges

    A charge registered on 04 Sep 2024 via Charge ID 100974582 with Others was fully satisfied on 05 Apr 2025. was recorded as a recent event.

  • Charges

    Progress on A charge registered on 27 Jun 2023 via Charge ID 100750207 with Others was fully satisfied on 01 Apr 2025. was documented.

  • Charges

    A charge with Others amounted to Rs. 75.00 Cr with Charge ID 101090172 was registered on 27 Mar 2025. was recorded as a recent event.

Explore recent activity and updates - View Recent Activity

Recent News, Updates & Announcement

Explore news and more updates - View Recent News

Frequently Asked Questions
What is the CIN of Brinton Pharmaceuticals Limited?

The CIN of Brinton Pharmaceuticals Limited is U24232PN2013PLC148971.

Where is Brinton Pharmaceuticals Limited headquartered?

Brinton Pharmaceuticals Limited is headquartered at S. No 55/2 Kharadi, Taluka Haveli, Pune, Maharashtra, 411014.

When was Brinton Pharmaceuticals Limited incorporated?

Brinton Pharmaceuticals Limited was incorporated on 27 September 2013.

Who are the current directors of Brinton Pharmaceuticals Limited?

The current directors of Brinton Pharmaceuticals Limited are

What is the primary industry of Brinton Pharmaceuticals Limited?

The primary industry of Brinton Pharmaceuticals Limited is Trade.

Is Brinton Pharmaceuticals Limited a listed company?

Brinton Pharmaceuticals Limited is unlisted.

What is the capital structure of Brinton Pharmaceuticals Limited?

The authorized capital of Brinton Pharmaceuticals Limited is ₹2.00 Cr, and the paid-up capital is ₹1.09 Cr.

What is the compliance status of Brinton Pharmaceuticals Limited?

The compliance status of Brinton Pharmaceuticals Limited is Compliant.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available